serotonin receptor agonists

Preferred Label : serotonin receptor agonists;

MeSH definition : Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.;

MeSH synonym : serotonin agonist; 5 ht agonist; agonist, 5-ht; 5 hydroxytryptamine agonists; agonists, 5-ht; serotonergic agonists; 5-hydroxytrytamine agonist; agonist, 5-hydroxytrytamine; serotonergic agonist; agonist, serotonin receptor; 5-ht agonist; agonists, serotonergic; agonist, serotonin; serotonin receptor agonist; receptor agonist, serotonin; serotonin agonists; agonists, serotonin; 5-ht agonists; 5 ht agonists; 5-hydroxytryptamine agonists; agonists, 5-hydroxytryptamine; 5 hydroxytrytamine agonist; receptor agonists, serotonin; agonists, serotonin receptor; agonist, serotonergic;

MeSH annotation : general or unspecified; prefer specifics; note entry term SEROTONIN AGONISTS: do not confuse with SEROTONIN ANTAGONISTS;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D017366;

UMLS CUI

C0162757;

ATC code(s)
- almotriptan [ATC Code]
- eletriptan [ATC Code]
- frovatriptan [ATC Code]
- naratriptan [ATC Code]
- rizatriptan [ATC Code]
- sumatriptan [ATC Code]
- zolmitriptan [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Serotonin (substance) [SNOMED CT concept]
- Serotonin receptor agonist (disposition) [SNOMED CT concept]
- Substance with serotonin receptor agonist mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Serotonin Agonist [NCIt concept]
Indexing information
- 2-(1H-imidazol-4-ylmethyl)-8H-indeno(1,2-d)thiazole [MeSH Supplementary Concept]
- 2-(2-(dimethylamino)ethyl)-4-(1,3,5-trimethyl-1H-pyrazol-4-yl)phenol [MeSH Supplementary Concept]
- PF 3246799 [MeSH Supplementary Concept]
- SDZ 219-964 [MeSH Supplementary Concept]
- lasmiditan [MeSH Supplementary Concept]
- repinotan hydrochloride [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, serotonin [MeSH Descriptor]
- serotonin [MeSH Descriptor]
Record concept(s)
- serotonin receptor agonists [MeSH concept]
See also (suggested by CISMeF)
- receptors, serotonin [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (3,4-dichlorophenyl)(4-((6-azetidinopyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone [MeSH Supplementary Concept]
- (3,4-dichlorophenyl)(4-((6-oxazol-5-ylpyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone [MeSH Supplementary Concept]
- 1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine [MeSH Supplementary Concept]
- 1-(3-chlorophenyl)biguanide [MeSH Supplementary Concept]
- 1-(3-chlorophenyl)piperazine [MeSH Supplementary Concept]
- 1-(3-trifluoromethylphenyl)piperazine [MeSH Supplementary Concept]
- 2,5-dimethoxy-4-bromoamphetamine [MeSH Supplementary Concept]
- 3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide [MeSH Supplementary Concept]
- 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one [MeSH Supplementary Concept]
- 3-(3-(N-(alpha-methylbenzyl)aminomethyl)pyrrolidiny)-5-((2-oxooxazolidinyl)methyl)indole [MeSH Supplementary Concept]
- 3-(3-(N-benzylaminomethyl)pyrrolidinyl)-5-((2-oxooxazolidin-4-yl)methyl)indole [MeSH Supplementary Concept]
- 4-(2-methylthiophenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide [MeSH Supplementary Concept]
- 4-(4-(3-methoxyphenyl)cyclohexyl)-1-(2-pyridinyl)piperazine [MeSH Supplementary Concept]
- 4-fluoro-N-(3-(1-methyl-4-piperidinyl)-1H-indol-5-yl)benzamide [MeSH Supplementary Concept]
- 4-iodo-2,5-dimethoxyphenylisopropylamine [MeSH Supplementary Concept]
- 5-carboxamidotryptamine [MeSH Supplementary Concept]
- 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole [MeSH Supplementary Concept]
- 6-(4-methyl-1-piperazinyl)--7,8,9,10-tetrahydro-8,10-ethanophenanthridine [MeSH Supplementary Concept]
- 6-(4-methyl-1-piperazinyl)-7,8,9,10-tetrahydrophenanthridine [MeSH Supplementary Concept]
- 6-chloro-2-(1-piperazinyl)pyrazine [MeSH Supplementary Concept]
- 8-Hydroxy-2-(di-n-propylamino)tetralin [MeSH Descriptor]
- CGS 12066B [MeSH Supplementary Concept]
- CP 2289 [MeSH Supplementary Concept]
- DOM 2,5-Dimethoxy-4-Methylamphetamine [MeSH Descriptor]
- L 772405 [MeSH Supplementary Concept]
- LY 165163 [MeSH Supplementary Concept]
- LY 302148 [MeSH Supplementary Concept]
- LY 306258 [MeSH Supplementary Concept]
- N,N-Dimethyltryptamine [MeSH Descriptor]
- N-(3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl)-4-fluorobenzamide [MeSH Supplementary Concept]
- N-(4-(3-methoxyphenyl)cyclohexyl)-2-(2-pyridyloxy)ethylamine [MeSH Supplementary Concept]
- N-methyl-5-tert-butyltryptamine [MeSH Supplementary Concept]
- PD 158771 [MeSH Supplementary Concept]
- RS 67532 [MeSH Supplementary Concept]
- SDZ 219-964 [MeSH Supplementary Concept]
- almotriptan [MeSH Supplementary Concept]
- alnespirone [MeSH Supplementary Concept]
- alpha-methylserotonin [MeSH Supplementary Concept]
- binospirone mesylate [MeSH Supplementary Concept]
- buspirone [MeSH Descriptor]
- cisapride [MeSH Descriptor]
- dexfenfluramine [MeSH Descriptor]
- dimethoxy-4-indophenyl-2-aminopropane [MeSH Supplementary Concept]
- eletriptan [MeSH Supplementary Concept]
- eltoprazine [MeSH Supplementary Concept]
- ergotamine [MeSH Descriptor]
- flesinoxan [MeSH Supplementary Concept]
- frovatriptan [MeSH Supplementary Concept]
- gepirone [MeSH Supplementary Concept]
- indorenate [MeSH Supplementary Concept]
- ipsapirone [MeSH Supplementary Concept]
- lasmiditan [MeSH Supplementary Concept]
- lisuride [MeSH Descriptor]
- lysergic acid diethylamide [MeSH Descriptor]
- mescaline [MeSH Descriptor]
- mosapride [MeSH Supplementary Concept]
- phenyl biguanide [MeSH Supplementary Concept]
- quipazine [MeSH Descriptor]
- rizatriptan [MeSH Supplementary Concept]
- serotonin [MeSH Descriptor]
- tandospirone [MeSH Supplementary Concept]
- tegaserod [MeSH Supplementary Concept]
- urapidil [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing serotonin receptor agonist (product) [SNOMED CT concept]
- Serotonin Agonist [NCIt concept]
- Substance with serotonin receptor agonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients